GlassScriptPhysician profile
Susanna R Magee
NPI 1487638003
$1,436.04
in general payments reported to CMS, 2019-2025
19 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.19 · 2020: $15.37 · 2021: $77.49 · 2022: $160 · 2023: $144 · 2024: $506 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $232.71 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $206.38 | 2024-2025 | Veozah |
| Abbvie INC. | $138.47 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $134.87 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $124.82 | 2024-2025 | Zurzuvae |
| Cranial Technologies, INC | $103.15 | 2023-2025 | Doc Band |
| Exeltis, USA INC. | $91.19 | 2022-2023 | Tyblume, Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $82.19 | 2020-2025 | |
| Myovant Sciences INC. | $55.65 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $44.44 | 2021-2022 | |
| Davol INC. | $36.80 | 2024 | Arista Ah Flexitip |
| Coopersurgical, INC. | $36.17 | 2024-2025 | Paragard T 380a |
| Pfizer INC. | $33.97 | 2023 | |
| Medicomp INC | $32.26 | 2024 | Telepatch Cardiac Monitor |
| Lilly USA, LLC | $27.93 | 2025 | Mounjaro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.88 | 2019 | |
| Dexcom, INC. | $14.49 | 2024 | Dexcom G6 Transmitter |
| Watermark Medical, INC. | $13.83 | 2024 | |
| Echosens North America, INC. | $11.84 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanna Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.